Streetwise Articles
Diverse Pipeline for Repurposing Drug Company Includes Treatments for Idiopathic Pulmonary Fibrosis and Chronic Cough, Pancreatic Cancer and Stroke
Source: Streetwise Reports (6/30/21)
Repurposing extends a drug's reach and value, and Algernon Pharmaceuticals' strategy of finding and demonstrating new uses for existing drugs reduces risk, accelerates time to market and increases capital efficiency.
More >
Biotech Takes a 'Disruptive Drug Development Approach' to Destroy Dysregulated Transcription in Cancer
Source: Streetwise Reports (6/30/21)
Kronos Bio's key assets are reviewed in an H.C. Wainwright & Co. report.
More >
Vertex Energy Shares Rise 36% on Sale of Oil Collection and Recycling Portfolio
Source: Streetwise Reports (6/30/21)
Vertex Energy shares climbed to a new 52-week high after the company reported it entered into an agreement to sell its used motor oil collection and recycling assets to Safety-Kleen Systems for $140 million.
More >
'Most Prolific Royalty Generator on the Planet' Provides Optionality
Source: Maurice Jackson for Streetwise Reports (6/30/21)
David Cole, the CEO of EMX Royalty, talks to Maurice Jackson of Proven and Probable about recent developments at several properties where the firm owns royalties.
More >
Helium Company 'Continues to Stand Out as a Leader in the North American Helium Pubco Space'
Source: Streetwise Reports (6/29/21)
Royal Helium's recent financing, its path to first production and its resource growth plan are all discussed in a Cormark Securities report.
More >
Small-Cap Firm's AI Technology Finds a Large Niche with the 'Underbanked'
Source: Streetwise Reports (6/29/21)
Marble Financial is aggressively expanding its groundbreaking programs for the financially underserved, with plans for hockey stick growth from the current 20,000 users to 100,000 by year-end, and 1 million users in 2022.
More >
Solar Company's Project Backlog 'Anticipated to Result in High Margin Recurring Revenue Stream'
Source: Streetwise Reports (6/29/21)
An addition to UGE International's project backlog is covered in a PI Financial report.
More >
Spanish Court Decisions 'Appear to Favor' Canadian Explorer in Tender Process
Source: Streetwise Reports (6/29/21)
A Research Capital Corp. report discusses how Spanish court decisions affect Emerita Resources and why it believes the company is an excellent vehicle for investors to gain exposure to very promising base metal projects in Spain.
More >
Precision Mapping Firm Awarded Patent for Mobile Devices Managing Critical Utility Assets
Source: Streetwise Reports (6/29/21)
ProStar Holdings reported it has been granted a major Canadian pioneer patent for ProStar that allows mobile devices to capture utility asset data and transmit the information to the cloud and back office.
More >
The Great Debate: Inflation Versus Deflation
Source: Michael Ballanger for Streetwise Reports (6/29/21)
Sector expert Michael Ballanger argues that markets are better used as barometers than thermometers, and warns current Federal Reserve policy protects the wealth of bankers, not citizens.
More >
Cerevel Shares More Than Double on Positive Topline Results in Phase 1b Schizophrenia Trial
Source: Streetwise Reports (6/29/21)
Shares of Cerevel Therapeutics hit a new 52-week high after the company released positive topline results for its CVL-231 in a Phase 1b clinical trial in schizophrenia patients.
More >
Innovative Diesel Catalytic Converter Platinum and Palladium Recycling Nearly Ready for Prime Time
Source: Streetwise Reports (6/28/21)
Mineworx's disruptive technology will be used in a new plant that will produce platinum and palladium and is projected to generate up to $100 million in revenue annually.
More >
Meridian Mining Continues to Deliver at CabaƧal with More Strong Results
Source: The Critical Investor for Streetwise Reports (6/28/21)
The Critical Investor profiles Meridian Mining's latest drill results and notes that the company recently raised CA$2.73 million from the ongoing exercise of warrants.
More >
Intellia Shares Rise 49% on 'Landmark' Interim Results in Phase 1 ATTR Amyloidosis Trial
Source: Streetwise Reports (6/28/21)
Intellia Therapeutics soared to a new 52-week high after the firm reported that in a Phase 1 clinical study with partner Regeneron, it had achieved "landmark clinical data" that demonstrated deep reduction in disease-causing protein after a single infusion of NTLA-2001, an investigational CRISPR therapy for transthyretin (ATTR) amyloidosis.
Why This Royalty Company Believes It Is a Good Way to Play Commodities and Inflation
Source: Streetwise Reports (6/25/21)
In a Streetwise Live broadcast on June 22, 2021, Vox Royalty CEO Kyle Floyd and VP of Corporate Development Simon Cooper discuss investing in a royalty company for exposure to commodities and protection against inflation.
Explorer Prepares to Go Deep on Nevada Gold Property
Source: Streetwise Reports (6/25/21)
Cyon Exploration has a new name, new management and is about to start drilling deep.
More >
Solar Installations Steady but Polysilicon Costs Climb, Extending Delays
Source: McAlinden Research for Streetwise Reports (6/25/21)
McAlinden Research Partners maintains that robust corporate and governmental investment in renewable energy should drive global solar installations higher in 2021, while noting that the industry will continue to struggle with supply-side headwinds and volatility ahead.
More >
Virgin Galactic Shares Blast Off After FAA Approves Full Commercial Launch License
Source: Streetwise Reports (6/25/21)
Shares of Virgin Galactic Holdings traded more than 30% higher after the company reported it received approval from the U.S. Federal Aviation Administration for a full commercial license following its successful test flight last month.
More >
Exploration Program Offers 'Potential to Make Multiple Discoveries'
Source: Streetwise Reports (6/24/21)
Aurania Resources' recent drilling efforts, results and plans are addressed in a Noble Capital Markets report.
More >
'Undervalued' Helium Company Presents 'Key Opportunity' for Investors
Source: Streetwise Reports (6/24/21)
The factors making Royal Helium stock attractive are outlined in an Eight Capital report.
More >
Coverage Initiated on 'New Iberian Pyrite Belt, Zinc-Focused Company'
Source: Streetwise Reports (6/24/21)
Emerita Resources' projects and upside potential are discussed in a Research Capital Corp. report.
More >
Lithium Play Poised to Add Properties, Explore Brine Deposits in Argentina
Source: Streetwise Reports (6/24/21)
Argentina Lithium is operating in the "lithium triangle" in a country where Joe Grosso and his team have made more big discoveries than anyone else.
More >
NASDAQ-Traded Drone Company Navigating a Big Field, Sees Blue Skies Ahead with Its 'Hardware-Enabled Software Platform'
Source: Streetwise Reports (6/24/21)
Red Cat Holdings, which is building "a very high margin monthly recurring revenue business model" through its four subsidiaries, with plans to add more in 2021 and beyond, has been selected to join the Russell MicrocapĀ® Index.
More >
As Cybersecurity Threats Grow Globally, This Company's Technology Can Help Ensure Digital Identity
Source: Streetwise Reports (6/24/21)
Liquid Avatar's biometric facial recognition technology empowers users to manage and take control over storage and use of personal data in protecting digital credentials, and offers brand names an innovative way to reach consumers.
More >
Eli Lilly Receives FDA Breakthrough Therapy Designation for Alzheimer's Treatment
Source: Streetwise Reports (6/24/21)
Eli Lilly and Co's shares traded 8% higher and reached a new 52-week high after the company reported the FDA granted its investigational antibody therapy donanemab Breakthrough Therapy designation for use in treating Alzheimer's disease.
More >
